StudyOpioid use disorder2024
Thakrar 2024: buprenorphine-precipitated withdrawal in hospital patients
Thakrar AP, Christine PJ, Siaw-Asamoah A, et al. Buprenorphine-precipitated withdrawal among hospitalized patients using fentanyl
This records study measured how often buprenorphine set off sudden withdrawal, not naltrexone. The site cites it alongside naltrexone because both medicines can cause precipitated withdrawal, and its guide compares them.
What it found
Of 226 hospital and emergency department patients who started buprenorphine, 26 (11.5%) had precipitated withdrawal, and among the 123 with confirmed fentanyl use, 20 (16.3%) did. A body mass index of 30 or more and a urine fentanyl level of 200 ng/mL or more were linked to higher odds.
- Had precipitated withdrawal
- 26 (11.5%)
- Among those with confirmed fentanyl use
- 20 of 123 (16.3%)
- BMI 30 or more vs under 25
- AOR 5.12
- Urine fentanyl 200 ng/mL or more vs under 20
- AOR 8.37
What they tested
Researchers reviewed records at three academic hospitals in Philadelphia for adults with opioid use disorder who began buprenorphine between January 2020 and December 2021, with a first dose of at least 2 mg under the tongue after a Clinical Opiate Withdrawal Scale (COWS) score of 8 or more. People started on low-dose regimens, or without a withdrawal score recorded within 4 hours, were left out.
Precipitated withdrawal, a sudden worsening of withdrawal caused by the medicine, was defined as a rise of 5 or more COWS points from just before to within 4 hours after the first dose. Four possible risk factors were examined: withdrawal severity beforehand, first dose, body mass index (BMI) and urine fentanyl level.
What they found
Overall, 26 of 226 patients (11.5%) met the definition. Among them, the median rise in COWS score was 9 points.
Of 123 patients with confirmed fentanyl use, 20 (16.3%) had precipitated withdrawal.
A BMI of 30 or more, compared with under 25, was linked to higher odds (adjusted odds ratio 5.12, 95% CI 1.31-19.92). So was a urine fentanyl level of 200 ng/mL or more, compared with under 20 ng/mL (adjusted odds ratio 8.37, 95% CI 1.60-43.89). Both confidence intervals were wide.
Limits
- It was a look back at records from three hospitals in one city.
- People without a withdrawal score recorded within 4 hours were excluded, which could shift the rate either way.
- The risk-factor estimates were imprecise, and the authors say the rate, and whether fentanyl built up in the body is a risk factor, need confirming.
What it means if you're considering naltrexone
Estimates of how often buprenorphine causes precipitated withdrawal vary between studies: this one found 11.5% in hospital patients, while a large emergency department trial (D'Onofrio 2023) found under 1%. The study concerns buprenorphine only. Naltrexone's own precipitated withdrawal risk is covered in the site's precipitated withdrawal guide.
Frequently asked questions
Does fentanyl make buprenorphine withdrawal more likely?
In this study, 16.3% of patients with confirmed fentanyl use had precipitated withdrawal, against 11.5% overall. A urine fentanyl level of 200 ng/mL or more was linked to higher odds (adjusted odds ratio 8.37), with a wide confidence interval.
The paper
Thakrar AP, Christine PJ, Siaw-Asamoah A, et al. Buprenorphine-precipitated withdrawal among hospitalized patients using fentanyl. JAMA Netw Open. 2024;7(9):e2435895. doi:10.1001/jamanetworkopen.2024.35895
Read the paperdoi:10.1001/jamanetworkopen.2024.35895
We wrote this page from the paper's published abstract, and the study's numbers here come from there. Updated October 17, 2026.
Medical disclaimer
This page is for information only and is not medical advice, diagnosis, or treatment. Don't start, stop, or change any medicine — including naltrexone — without your prescriber. Naltrexone must not be used by people taking opioid pain medicines, people dependent on opioids, or people in opioid withdrawal (FDA label). In an emergency call 911; for crisis support call or text 988. Full medical disclaimer.